Revenue, 2025
USD 3.83 Bn
Forecast Year, 2034
USD 6.50 Bn
CAGR, 2025 - 2034
6.06%
Report Coverage
Worldwide
The global antimicrobial susceptibility testing market, valued at over USD 3.83 billion in 2025, is projected to reach USD 6.50 billion by 2034, expanding at a CAGR of 6.06%, driven by rising infectious diseases and advanced diagnostic adoption.
Antimicrobial Susceptibility Testing Market Size Analysis
Antimicrobial Susceptibility Testing Market Size By Product Type 2025 to 2034 (USD Billion)
| Product Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Manual Products | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.97 | 1.03 | 1.09 |
| Automated Products | 1.27 | 1.35 | 1.44 | 1.52 | 1.61 | 1.71 | 1.82 | 1.93 | 2.05 | 2.17 |
| Consumables | 1.91 | 2.03 | 2.15 | 2.28 | 2.42 | 2.57 | 2.71 | 2.89 | 3.05 | 3.24 |
Antimicrobial Susceptibility Testing Market Size By Method Type 2025 to 2034 (USD Billion)
| Method Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| ETEST | 0.38 | 0.41 | 0.43 | 0.46 | 0.49 | 0.52 | 0.55 | 0.58 | 0.62 | 0.65 |
| Disks Diffusion | 0.77 | 0.81 | 0.87 | 0.91 | 0.97 | 1.03 | 1.09 | 1.16 | 1.23 | 1.30 |
| Rapid Automation Method | 1.15 | 1.22 | 1.29 | 1.37 | 1.46 | 1.54 | 1.64 | 1.73 | 1.84 | 1.96 |
| Others | 1.53 | 1.62 | 1.72 | 1.83 | 1.93 | 2.05 | 2.18 | 2.31 | 2.45 | 2.60 |
Antimicrobial Susceptibility Testing Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals & Diagnostic Laboratories | 0.64 | 0.68 | 0.72 | 0.76 | 0.81 | 0.85 | 0.91 | 0.97 | 1.03 | 1.08 |
| Pharmaceutical & Biotechnology Companies | 1.27 | 1.36 | 1.43 | 1.52 | 1.62 | 1.72 | 1.82 | 1.93 | 2.04 | 2.17 |
| Others | 1.92 | 2.02 | 2.16 | 2.28 | 2.42 | 2.57 | 2.73 | 2.88 | 3.06 | 3.25 |
Antimicrobial Susceptibility Testing Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.38 | 0.41 | 0.43 | 0.46 | 0.49 | 0.51 | 0.55 | 0.58 | 0.61 | 0.66 |
| LAMEA | 0.77 | 0.81 | 0.86 | 0.92 | 0.97 | 1.03 | 1.09 | 1.15 | 1.23 | 1.30 |
| Europe | 1.15 | 1.22 | 1.29 | 1.37 | 1.45 | 1.55 | 1.63 | 1.74 | 1.84 | 1.95 |
| Asia-Pacific | 1.53 | 1.63 | 1.72 | 1.82 | 1.94 | 2.05 | 2.18 | 2.31 | 2.45 | 2.59 |
Antimicrobial Susceptibility Testing Market Size to Hit USD 6.50 Billion by 2034
The global antimicrobial susceptibility testing market size surpassed USD 3.83 billion in 2025 and is predicted to reach around USD 6.50 billion by 2034 with a registering a CAGR of 6.06%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com